Healthcare Triangle completes 1-for-20 reverse split amid Nasdaq delisting review
Healthcare Triangle, Inc. completed a 1-for-20 reverse stock split effective October 26, 2026, reducing its common shares outstanding from 17,730,008 to 886,587. The company said the split is intended to meet Nasdaq's $1.00 minimum bid price requirement. Nasdaq has issued a Staff Delisting Determination, and a Nasdaq Hearings Panel hearing is scheduled for November 5, 2026, with no assurance the company will keep its listing.
Key points
- 1-for-20 reverse split effective 12:01 a.m. ET on October 26, 2026; shares trade split-adjusted on the Nasdaq Capital Market under HCTI
- Common shares outstanding reduced from 17,730,008 to 886,587; authorized shares unchanged
- Nasdaq Staff Delisting Determination received October 1, 2026; company requested a Panel hearing October 8, 2026
- Hearing before the Nasdaq Hearings Panel scheduled for November 5, 2026; company states there can be no assurance of continued listing
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.